Trial stimulation systems
AssigneeMedtronic, Inc.
InventorsJohn Shishilla, Kathryn A. Pederson, Mukul Jain, Nicholas S. Mairs
Life of this patent
Estimating the term…
Abstract
A trial stimulation system includes a disposable trial electrical stimulator that, in some examples, is sterilized for a single use in a stimulation trial of one patient. Additionally, systems for securing a disposable trial stimulator to the body of a patient are described, which may function to improve the durability of the system during the trial period and reduce the risk of damage or malfunction to the system due to lead/electrode dislocation and/or off-label uses like showering or bathing with the trial stimulator still secured to the body.
Claims22
A medical system comprising:
- a disposable trial electrical stimulator comprising a single user interface integral with the trial stimulator;
- at least one percutaneous stimulation lead connected to the trial stimulator;
- and
- an electronic programming device configured to wirelessly communicate with the trial stimulator to program the trial stimulator to deliver stimulation therapy via the at least one percutaneous stimulation lead,
- wherein the user interface is configured to cause the trial stimulator to be capable of wireless communications with the electronic programming device and to turn off stimulation being delivered by the trial stimulator.
A method comprising:
- implanting at least one percutaneous stimulation lead to deliver stimulation to a target tissue location;
- connecting the at least one percutaneous stimulation lead to a disposable trial stimulator comprising a single user interface integral with the trial stimulator, wherein the user interface is configured to cause the trial stimulator to be capable of wireless communications with the programmer and to turn off stimulation being delivered by the trial stimulator;
- programming the trial stimulator to deliver stimulation via the at least one percutaneous stimulation lead with an electronic programming device configured to wirelessly communicate with the trial stimulator;
- delivering stimulation to the target tissue location via the at least one percutaneous stimulation lead with the trial stimulator for a trial period of time;
- and
- disposing of the trial stimulator after expiration of the trial period of time.
Dependencies are inferred from the claim text.